Search

Search Constraints

You searched for: Author/Creator Oh, D

Search Results

1. 160PClinical outcomes of second-line chemotherapy after progression on nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma. (24th November 2019)

2. LBA-001Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. (2nd July 2019)

3. O-002Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study. (2nd July 2019)

4. P-225Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF trial. (2nd July 2019)

5. PD-001Analysis of patient screening in the phase III, international, randomized, open-label APACT trial. (2nd July 2019)

6. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Issue 2 (4th June 2015)

7. SO-003Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: preliminary results. (2nd July 2019)

8. Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1, 000 patient registry. Issue 9 (30th April 2019)